Roche near deal to buy rest of Genentech: report
March 09, 2009 at 13:52 PM EDT
The board of directors of Genentech Inc. is reportedly near a deal to sell the remaining shares of the company to Swiss drug giant Roche Holding AG for $95 a share, which would give the deal a total value of $46.7 billion.
